Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...

PolyActiva is taking its high-precision glaucoma implant to global trials in a test for Australia’s biotech ambitions.

Rhythm stock is approaching its all-time high in a long base. Rhythm makes drugs to treat disorders due to genetic changes.

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...

The biotech is fighting to preserve its cash while continuing to push its key cancer treatment through clinical trials. HHS ...

NRI PULSE STAFF REPORT Four Indian American women have secured prominent spots on Fortune’s 2025 Most Powerful Women in ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...